- Nachrichtendetail
-
24.06.2024 08:07:05 - dpa-AFX: *GSK: EMA ACCEPTS JEMPERLI+ CHEMOTHERAPY APPLICATION FOR REVIEW TO EXPAND USE FOR PATIENTS WITH ENDOMETRIAL CANCER
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
GSK PLC LS-,3125 | A3DMB5 | Xetra | 18,220 | 02.10.24 10:34:10 | -0,100 | -0,55% | 18,175 | 18,205 | 18,245 | 18,320 |
